Abstract Submission

Abstract submission is now open for Late-Breaking Research abstracts. Deadline for submission is 28 February 2019.

Notifications of the first round of submitted abstracts for accept or reject will be send directly to abstract submitters latest 4 March 2019.

 

Due to a higher volume than expected submitted abstracts, the notifications will be send on 5 March 2019!!

 

Notifications for late breaking research abstracts will be send before or on 1 April 2019.

 

NB: Abstracts presented at previous ILF conferences will not be accepted, unless new extended information has been applied.


Late-Breaking Research Abstract Submission

The ILF defines Late-Breaking Research as a project that was incomplete at the abstract deadline for Completed Research, but has since concluded and is able to be presented with results and conclusions. 

The research must be novel, innovative, contemporary, and of highscientic significance to deserve special consideration after the original abstract deadline. Abstracts should describe either large clinical investigations or high-impact translational research that could not becompleted prior to the original deadline.

You will be required to answer the question “why is this abstract considered late-breaking?”

Late-breaking abstracts must not be a revision of an abstract submittedprior to the original submission deadline.

Late-breaking abstracts must not have been presented, accepted for presentation, or published at any other scientic meeting or journal at the time of submission.

 

All abstract submissions must be made electronically through ILF online abstract submission system. The late-breaking abstracts site opens on 8 February 2019, and the deadline for late-breaking abstract submission is 28 February 2019, at 11:59 p.m. CET.

Notification regarding acceptance or rejection of abstracts will be sent to the presenting author on or after 1 April 2019.

 

Before starting the submission, please read the submission guidelines and conditions below.

They are intended to help to present your abstract(s) in a clear and concise framework.

 

 


Abstracts can be submitted in the following categories:

  • Innovative and promising approaches including technologies
  • Outcome measures
  • Complex chronic oedema case studies including chronic wounds 
  • Health economics
  • Pediatric and primary lymphoedema 
  • National frameworks and other community organization initiatives
  • Service development/enhancement initiatives
  • Educational initiatives
  • Patient/carer engagement or self-management initiatives
  • Conservative treatment including compression 
  • Surgical options 
  • Psychosocial and qualitative research
  • Risk reduction practices
  • Imaging & diagnostics 
  • Obesity and lymphedema/lipedema 
  • Basic Science and Biology 
  • Other


Please refer to the guidelines above to see what the various categories should include.

If you have any questions, please contact the ILF conference secretariat at info@cap-partner.eu.